stockrow
Friday 6 November 2026
Export ITOC’s income statement to Excel — free account
iTonic Holdings Ltd.
ITOC Healthcare Medical Devices
iTonic Holdings Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $523,000.00, up 16.7% from fiscal 2024.
1.68
0.02
−1.18%
Follow ITOC
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | 1 | 1 | 0 | 1 | — | (8.4%) | — | — | — | — | |
| Gross margin, % | — | — | — | — | — | — | 82.11 | 74.90 | 85.05 | 62.60 | — | (19.5) pt | ||||||
| EBT | — | — | — | — | — | — | 0 | 0 | (1) | (5) | — | n/m | ||||||
| EBT margin, % | — | — | — | — | — | — | 10.44 | (41.44) | (142.53) | (974.84) | — | (985.3) pt | ||||||
| Net income | — | — | — | — | — | — | 0 | 0 | (1) | (5) | (6) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | 0.91 | 0.84 | 0.56 | 0.52 | — | (16.8%) | |||||
| Earnings | — | — | — | — | — | — | 0.11 | (0.32) | (0.83) | (5.12) | — | n/m | ||||||
| Cash flow | — | — | — | — | — | — | (0.15) | (0.08) | (0.97) | (3.22) | 0.00 | +175.1% | ||||||
| Capex | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/m | ||||||
| Free cash flow | — | — | — | — | — | — | (0.15) | (0.08) | (0.98) | (3.23) | 0.00 | +175.2% | ||||||
| Book value | — | — | — | — | — | — | 0.74 | 0.41 | 7.78 | 8.11 | 0.00 | +121.9% | ||||||
| Shares, m | — | — | — | — | — | — | 1 | 1 | 1 | 1 | — | +10.1% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| P/B | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/Sales | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/FCF | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.66 | 0.49 | 0.2 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | 0 | 0 | (1) | (3) | (4) | +203.0% | |||||
| Capex | — | — | — | — | — | — | — | — | 0 | 0 | 0 | +322.2% | ||||||
| Free cash flow | — | — | — | — | — | — | 0 | 0 | (1) | (3) | (4) | +203.1% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | 0 | (1) | 6 | 4 | 23 | +355.4% | |||||
| Net debt | — | — | — | — | — | — | 0 | 0 | (6) | (3) | (2) | +237.6% | ||||||
| Shareholders’ equity | — | — | — | — | — | — | 1 | 0 | 6 | 8 | 25 | +144.5% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | 0.00 | (15.98) | (15.84) | (64.45) | 0.00 | (64.4) pt | |||||
| ROIC | — | — | — | — | — | — | 3.55 | (243.26) | (176.42) | (60.67) | 0.00 | (64.2) pt | ||||||
| ROE | — | — | — | — | — | — | 0.00 | (55.92) | (20.35) | (71.24) | 0.00 | (71.2) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 11 | 10 | 7 | — | (20.2%) | |||||
| Revenue/emp, $m | — | — | — | — | — | — | 0.00 | 0.06 | 0.04 | 0.07 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · fundamentals updated 2 Nov 2026
iTonic Holdings Ltd. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| RBOT Vicarious Surgical Inc. | $14.3M | — (loss-making) | — | — | n/m | +47.33% (above 0%: growing) | 0.00% | 0.00% | Compare |
| HSCS HeartSciences Inc. | $13.3M | — (loss-making) | — (loss-making) | −46.15% (below 0%: shrinking) | n/m | +18.18% (above 0%: growing) | 61.90% | (139,957.14%) | Compare |
| PETV PetVivo Holdings, Inc. | $12.9M | — (loss-making) | — (loss-making) | +13.48% (above 0%: growing) | n/m | +40.13% (above 0%: growing) | 66.14% | (476.54%) | Compare |
| ITOC iTonic Holdings Ltd. | $12.4M | — | — | — | — | — | — | — | |
| PAVM PAVmed Inc. | $12.4M | — (loss-making) | — (loss-making) | +450.00% (above 0%: growing) | n/m | −125.63% (below 0%: shrinking) | (269.70%) | (21,278.79%) | Compare |
| MODD Modular Medical, Inc. | $12.2M | — (loss-making) | — | — | n/m | −5.61% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| IRIX IRIDEX Corporation | $11.9M | — (loss-making) | — (loss-making) | −7.41% (below 0%: shrinking) | n/m | +130.24% (above 0%: growing) | 34.19% | (8.19%) | Compare |
| SINT SINTX TECHNOLOGIES, INC. | $11.5M | — (loss-making) | — (loss-making) | +952.88% (above 0%: growing) | n/m | +47.37% (above 0%: growing) | 62.19% | (74.66%) | Compare |
| BTCY Biotricity Inc. | $10.9M | — (loss-making) | — (loss-making) | +10.40% (above 0%: growing) | n/m | +235.83% (above 0%: growing) | 82.55% | 3.70% | Compare |
| Median of peers | $12.3M | — | — | +11.94% | — | +43.73% | 48.05% | (41.42%) |